Nephrology Department 1

The Department of Nephrology of the Second Hospital of Dalian Medical University was founded in the 1950s. It is a key discipline of Liaoning Province and Dalian City, and ranked eighth in nephrology on the 2020 China Hospital Rankings Northeast Specialty Reputation List. In 2013, the Nephrology Division 1 subspecialty was established. The department has a total of 12 physicians, including 4 with doctoral degrees, 8 with master's degrees, 2 full professors and 3 associate professors.

The main diagnostic and treatment directions include: 1. Blood purification and interventional nephrology treatment 2. Diagnosis and treatment of various primary and secondary glomerular diseases. At present there are a total of 46 beds, 2 blood purification centers and 114 hemodialysis machines, making it one of the largest hemodialysis centers in the country. It has a first-class peritoneal dialysis center in China, with more than 200 patients currently under follow-up for peritoneal dialysis. Our department performs routine arteriovenous fistula surgery as well as surgery for difficult fistulas, such as: fistula thrombectomy, fistula closure, interventional treatment of fistula stenosis, balloon dilation, etc. At the same time, it performs long-term central venous catheter implantation, with an annual surgical volume leading within the province. Our department has an independent nephrology laboratory and a renal pathology diagnostic center, and can independently carry out specialized nephrology diagnostic items, including the specific marker PLA2R for the diagnosis of membranous nephropathy, etc. The volume of renal needle biopsies exceeds 300 cases per year, and we have close cooperation with medical centers of high level in renal pathology diagnosis in China: such as Huashan Hospital affiliated to Fudan University in Shanghai, and Union Hospital affiliated to Huazhong University of Science and Technology in Wuhan. At present, the pathology diagnostic level of our department is among the leading in China. In the diagnosis and treatment of primary and secondary glomerular diseases, we closely follow international trends, standardize treatment protocols, and have accumulated rich clinical experience.